WFRDMEDIUM SIGNALFINANCIAL10-K

WFRD shows mixed financial performance with revenue growth of 18.8% offset by declining profitability metrics and reduced capital investment.

The company demonstrates solid top-line growth while experiencing margin compression, as evidenced by declining gross profit despite higher revenues. The addition of a comprehensive capital allocation framework including increased dividends and share repurchases suggests management confidence in future cash generation, though current profitability trends warrant monitoring.

Comparing 2026-02-04 vs 2025-02-06View on EDGAR →
FINANCIAL ANALYSIS

WFRD delivered solid revenue growth of 18.8% to $4.3B but experienced margin pressure with gross profit declining 10.5% and operating income falling 19.4%. The company strengthened its balance sheet position with stockholders' equity increasing 32.2% to $1.7B while reducing total debt by 10.8%, and management reduced capital expenditure by 24.4% which contributed to lower operating cash flow of $676M.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+32.2%
$1.3B$1.7B

Equity base grew 32.2% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Capital Expenditure
Cash Flow
-24.4%
$299.0M$226.0M

Capex reduced 24.4% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Operating Income
P&L
-19.4%
$938.0M$756.0M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Revenue
P&L
+18.8%
$3.6B$4.3B

Revenue growing 18.8% — solid top-line momentum, watch margins for quality of growth.

Net Income
P&L
-14.8%
$506.0M$431.0M

Net income declined 14.8% — review whether driven by operations, interest costs, or non-recurring items.

Operating Cash Flow
Cash Flow
-14.6%
$792.0M$676.0M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

R&D Expense
P&L
-12.2%
$123.0M$108.0M

R&D spending cut 12.2% — could signal cost discipline or concerning reduction in innovation investment.

Total Debt
Balance Sheet
-10.8%
$1.6B$1.4B

Debt reduced 10.8% — deleveraging strengthens balance sheet and reduces financial risk.

Gross Profit
P&L
-10.5%
$1.2B$1.1B

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

LANGUAGE CHANGES
NEW — 2026-02-04
PRIOR — 2025-02-06
ADDED
The registrant had 71,717,593 ordinary shares outstanding as of January 30, 2026.
Our strategic focus is enabled by a comprehensive capital allocation framework that includes: Improved through-cycle resilience from a strong balance sheet; Judicious business investments in technology and infrastructure upgrades to drive portfolio differentiation and structural cost efficiencies leading to improved returns; Strategic and disciplined mergers and acquisitions that align with our portfolio strategy; and Shareholder returns program as introduced in 2024 with a $500 million share repurchase authorization over three years.
Annual dividend program recently increased from $1.00 to $1.10 per share.
Production and Intervention ( PRI ) includes technologies that deliver a complete production ecosystem ranging from boosting productivity to responsible well abandonment for our customers.
Pressure Pumping Services offers advanced engineered fluid chemistry products and solutions and associated pumping services for safe and effective production enhancement.
+7 more — sign up free →
REMOVED
The registrant had 72,846,372 ordinary shares outstanding as of February 1, 2025.
Production and Intervention ( PRI ) offers production optimization technologies through our ability to design and deliver a complete production ecosystem ranging from boosting productivity to responsible well abandonment for our customers.
Pressure Pumping Services offers advanced chemistry-based solutions and associated pumping services for safe and effective production enhancement.
Revenues in Russia were approximately 5% of our total revenue for the year ended December 31, 2024, and were approximately 6% of our total revenues for the year ended December 31, 2023 and 7% for the year ended December 31, 2022.
As of December 31, 2023, our Russia operations included $62 million in cash, $94 million in other current assets, $76 million in property, plant and equipment and other non-current assets, and $62 million in liabilities.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →